Top Markets
Coin of the day
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Kedudukan dalam Saham #25241
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Harga Saham
$23.57
Disegerakkan terakhir: 2026-08-20
Modal Pasaran
$51.76M
Perubahan (1 hari)
-0.08%
Perubahan (1 tahun)
289.59%
Negara
US
Perdagangan Apollomics, Inc. (APLM)

Kategori

Sejarah harga saham bagi Apollomics, Inc. (APLM)
Harga penutupan tertinggi: $20.22 pada 2026-08-01

Harga penutupan terendah: $990.67 pada 2021-11-01
Sejarah harga saham Apollomics, Inc. dari 2021 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 0.80%
2025 83.86%
2024 -88.89%
2023 -91.94%
2022 3.60%
2021 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$758.49 8.17%
CH
$130.43 397.46%
US